Integrin (cid:1) D (cid:2) 2 , an adhesion receptor up-regulated on macrophage foam cells, exhibits multiligand-binding properties
暂无分享,去创建一个
[1] E. Fisher,et al. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[2] T. Ugarova,et al. Characterization of plasminogen as an adhesive ligand for integrins αMβ2 (Mac-1) and α5β1 (VLA-5) , 2004 .
[3] A. Lichtenberg,et al. Expression of CYR61, an Angiogenic Immediate Early Gene, in Arteriosclerosis and Its Regulation by Angiotensin II , 2002, Circulation.
[4] L. Lau,et al. Identification of a novel integrin alphaMbeta2 binding site in CCN1 (CYR61), a matricellular protein expressed in healing wounds and atherosclerotic lesions. , 2003, The Journal of biological chemistry.
[5] G. Getz. Thematic review series: The Immune System and Atherogenesis. Immune function in atherogenesis Published, JLR Papers in Press, November 16, 2004. DOI 10.1194/jlr.R400013-JLR200 , 2005, Journal of Lipid Research.
[6] I. Chaiken,et al. Tissue factor regulates plasminogen binding and activation. , 1998, Blood.
[7] M. Vuento,et al. Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions. , 1979, The Biochemical journal.
[8] M. Elices,et al. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/Fibronectin binding site , 1990, Cell.
[9] T. Ugarova,et al. A molecular basis for integrin alphaMbeta 2 ligand binding promiscuity. , 2002, The Journal of biological chemistry.
[10] M. Arnaout,et al. An Isoleucine-based Allosteric Switch Controls Affinity and Shape Shifting in Integrin CD11b A-domain* , 2000, The Journal of Biological Chemistry.
[11] E. Ruoslahti. Fibronectin and its receptors. , 1988, Annual review of biochemistry.
[12] R. Shankar,et al. Down regulation of CD11b and CD18 expression in atherosclerotic lesion-derived macrophages. , 1995, The American surgeon.
[13] M. Humphries,et al. Integrin structure. , 2000, Biochemical Society transactions.
[14] T. Ugarova,et al. Identification of a Novel Recognition Sequence for Integrin αMβ2 within the γ-chain of Fibrinogen* , 1998, The Journal of Biological Chemistry.
[15] T. Ugarova,et al. Differential Induction of Gelatinase B (MMP-9) and Gelatinase A (MMP-2) in T Lymphocytes upon α4β1-Mediated Adhesion to VCAM-1 and the CS-1 Peptide of Fibronectin☆ , 2000 .
[16] L. Lau,et al. Pro-angiogenic Activities of CYR61 (CCN1) Mediated through Integrins αvβ3 and α6β1 in Human Umbilical Vein Endothelial Cells* , 2002, The Journal of Biological Chemistry.
[17] E. Plow,et al. Fibrinogen Is a Ligand for Integrin α5β1 on Endothelial Cells* , 1997, The Journal of Biological Chemistry.
[18] L. Lau,et al. Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions. , 2002, Blood.
[19] D. Staunton,et al. αdβ2 Integrin Is a Ligand for Vascular Cell Adhesion Molecule–1 , 1999, International Archives of Allergy and Immunology.
[20] F. Fawthrop. Inflammation: Basic Principles and Clinical Correlates , 1993 .
[21] T. Ugarova,et al. Identification of the Binding Site for Fibrinogen Recognition Peptide γ383–395 within the αMI-Domain of Integrin αMβ2 * , 2001, The Journal of Biological Chemistry.
[22] T. Springer,et al. Chemoattractant-regulated mobilization of a novel intracellular compartment in human neutrophils. , 1987, Science.
[23] M. Hayashi,et al. Novel purification of vitronectin from human plasma by heparin affinity chromatography. , 1988, Cell structure and function.
[24] S. Lord,et al. Sequence γ377−395(P2), but Not γ190−202(P1), Is the Binding Site for the αMI-Domain of Integrin αMβ2 in the γC-Domain of Fibrinogen† , 2003 .
[25] S. L. McGuire,et al. Distinct Ligand Binding Sites in the I Domain of Integrin αMβ2 That Differentially Affect a Divalent Cation-dependent Conformation (*) , 1995, The Journal of Biological Chemistry.
[26] M. Humphries,et al. The Year 2000 Integrin Model , 2000 .
[27] T. Ugarova,et al. The interplay between integrins αmβ2 and α5β1 during cell migration to fibronectin , 2003 .
[28] D. Witte,et al. Leukocyte engagement of fibrin(ogen) via the integrin receptor αMβ2/Mac-1 is critical for host inflammatory response in vivo , 2004 .
[29] R. Liddington,et al. Two conformations of the integrin A-domain (I-domain): a pathway for activation? , 1995, Structure.
[30] G. Schmid-Schönbein,et al. Physiology and pathophysiology of leukocyte adhesion , 1995 .
[31] D. Staunton,et al. The leukocyte integrin alpha D beta 2 binds VCAM-1: evidence for a binding interface between I domain and VCAM-1. , 1999, Journal of immunology.
[32] John I. Gallin,et al. Inflammation: Basic Principles and Clinical Correlates , 1992 .
[33] T. Ugarova,et al. The alternatively spliced αeC domain of human fibrinogen-420 is a novel ligand for leukocyte integrins αMβ2 and αXβ2 , 2001 .
[34] D. Deutsch,et al. Plasminogen: Purification from Human Plasma by Affinity Chromatography , 1970, Science.
[35] T. Ugarova,et al. Integrin αMβ2-Mediated Cell Migration to Fibrinogen and Its Recognition Peptides , 2001, The Journal of experimental medicine.
[36] R. Liddington,et al. Crystal structure of the A domain from the a subunit of integrin CR3 (CD11 b/CD18) , 1995, Cell.
[37] J. Noti. Expression of the myeloid-specific leukocyte integrin gene CD11d during macrophage foam cell differentiation and exposure to lipoproteins. , 2002, International journal of molecular medicine.
[38] H. Ochs,et al. Identification of surface proteins mediating adherence of CD11/CD18-deficient lymphoblastoid cells to cultured human endothelium. , 1990, The Journal of clinical investigation.
[39] M. Arnaout,et al. of the Large Subunit of Mol (Mo1; formerly gp 110), a Surface Glycoprotein Associated with Neutrophil Adhesion , 1984 .
[40] L. Lau,et al. Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells. , 2002, The Journal of biological chemistry.
[41] D. Staunton,et al. A novel leukointegrin, αdβ2, binds preferentially to ICAM-3 , 1995 .
[42] M. Shimaoka,et al. Activation-induced Conformational Changes in the I Domain Region of Lymphocyte Function-associated Antigen 1* , 2002, The Journal of Biological Chemistry.
[43] M. Shimaoka,et al. An isolated, surface-expressed I domain of the integrin αLβ2 is sufficient for strong adhesive function when locked in the open conformation with a disulfide bond , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[44] D. Witte,et al. Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. , 2004, The Journal of clinical investigation.
[45] Timothy A. Springer,et al. Structure and allosteric regulation of the αXβ2 integrin I domain , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[46] A. Craig,et al. ICAM-3 interacts with LFA-1 and regulates the LFA-1/ICAM-1 cell adhesion pathway , 1993, The Journal of cell biology.